These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24658124)

  • 1. Patterns and predictors of self-medication in northern Uganda.
    Ocan M; Bwanga F; Bbosa GS; Bagenda D; Waako P; Ogwal-Okeng J; Obua C
    PLoS One; 2014; 9(3):e92323. PubMed ID: 24658124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting home storage of medicines in Northern Uganda.
    Ocan M; Bbosa GS; Waako P; Ogwal-Okeng J; Obua C
    BMC Public Health; 2014 Jun; 14():650. PubMed ID: 24964746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicine use practices in management of symptoms of acute upper respiratory tract infections in children (≤12 years) in Kampala city, Uganda.
    Ocan M; Aono M; Bukirwa C; Luyinda E; Ochwo C; Nsambu E; Namugonza S; Makoba J; Kandaruku E; Muyende H; Nakawunde A
    BMC Public Health; 2017 Sep; 17(1):732. PubMed ID: 28934933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antibacterials in the management of symptoms of acute respiratory tract infections among children under five years in Gulu, northern Uganda: Prevalence and determinants.
    Lanyero H; Eriksen J; Obua C; Stålsby Lundborg C; Nanzigu S; Katureebe A; Kalyango JN; Ocan M
    PLoS One; 2020; 15(6):e0235164. PubMed ID: 32574206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
    Staedke SG; Mwebaza N; Kamya MR; Clark TD; Dorsey G; Rosenthal PJ; Whitty CJ
    Lancet; 2009 May; 373(9675):1623-31. PubMed ID: 19362361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of self-medication with antibiotics and associated factors in the community of Asmara, Eritrea: a descriptive cross sectional survey.
    Ateshim Y; Bereket B; Major F; Emun Y; Woldai B; Pasha I; Habte E; Russom M
    BMC Public Health; 2019 Jun; 19(1):726. PubMed ID: 31182071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of an Intervention to Improve Malaria Care in Public Health Centers on Health Indicators of Children in Tororo, Uganda (PRIME): A Cluster-Randomized Trial.
    Staedke SG; Maiteki-Sebuguzi C; DiLiberto DD; Webb EL; Mugenyi L; Mbabazi E; Gonahasa S; Kigozi SP; Willey BA; Dorsey G; Kamya MR; Chandler CIR
    Am J Trop Med Hyg; 2016 Aug; 95(2):358-367. PubMed ID: 27273646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
    Balikagala B; Mita T; Ikeda M; Sakurai M; Yatsushiro S; Takahashi N; Tachibana SI; Auma M; Ntege EH; Ito D; Takashima E; Palacpac NM; Egwang TG; Onen JO; Kataoka M; Kimura E; Horii T; Tsuboi T
    Malar J; 2017 Jan; 16(1):23. PubMed ID: 28068997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
    Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G
    J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria.
    Wanzira H; Kakuru A; Arinaitwe E; Bigira V; Muhindo MK; Conrad M; Rosenthal PJ; Kamya MR; Tappero JW; Dorsey G
    Clin Infect Dis; 2014 Aug; 59(4):509-16. PubMed ID: 24825870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study.
    Nega D; Assefa A; Mohamed H; Solomon H; Woyessa A; Assefa Y; Kebede A; Kassa M
    PLoS One; 2016; 11(4):e0154618. PubMed ID: 27128799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring provider and community responses to the new malaria diagnostic and treatment regime in Solomon Islands.
    Wijesinghe RS; Atkinson JA; Bobogare A; Wini L; Whittaker M
    Malar J; 2011 Jan; 10():3. PubMed ID: 21219614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa.
    Ajayi IO; Browne EN; Bateganya F; Yar D; Happi C; Falade CO; Gbotosho GO; Yusuf B; Boateng S; Mugittu K; Cousens S; Nanyunja M; Pagnoni F
    Malar J; 2008 Sep; 7():190. PubMed ID: 18822170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practices and drivers of self-medication with antibiotics among undergraduate medical students in Eastern Uganda: A cross-sectional study.
    Nakato G; Adongo PR; Iramiot JS; Epuitai J
    PLoS One; 2023; 18(12):e0293685. PubMed ID: 38127886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
    Zurovac D; Ndhlovu M; Sipilanyambe N; Chanda P; Hamer DH; Simon JL; Snow RW
    Malar J; 2007 Mar; 6():31. PubMed ID: 17367518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.
    Kakuru A; Jagannathan P; Arinaitwe E; Wanzira H; Muhindo M; Bigira V; Osilo E; Homsy J; Kamya MR; Tappero JW; Dorsey G
    Am J Trop Med Hyg; 2013 Apr; 88(4):736-43. PubMed ID: 23382157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
    Bell DJ; Wootton D; Mukaka M; Montgomery J; Kayange N; Chimpeni P; Hughes DA; Molyneux ME; Ward SA; Winstanley PA; Lalloo DG
    Malar J; 2009 Aug; 8():204. PubMed ID: 19709418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participatory healthcare-provider orientation to improve artemether-lumefantrine-based drug treatment of uncomplicated malaria: a cluster quasi-experimental study.
    Anyama NG; Tibenderana JK; Kutyabami P; Kamba PF; Kitutu FE; Adome RO
    BMJ Qual Saf; 2012 Sep; 21(9):768-77. PubMed ID: 22927489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
    Kangwana BP; Kedenge SV; Noor AM; Alegana VA; Nyandigisi AJ; Pandit J; Fegan GW; Todd JE; Brooker S; Snow RW; Goodman CA
    PLoS Med; 2011 May; 8(5):e1000437. PubMed ID: 21655317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites.
    Ajayi IO; Browne EN; Garshong B; Bateganya F; Yusuf B; Agyei-Baffour P; Doamekpor L; Balyeku A; Munguti K; Cousens S; Pagnoni F
    Malar J; 2008 Jan; 7():6. PubMed ID: 18182114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.